Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers
This study has been completed.
Sponsor:
University of Pittsburgh
Collaborator:
GlaxoSmithKline
Information provided by:
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00436787
First received: February 16, 2007
Last updated: May 15, 2008
Last verified: May 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | December 2007 |
| Estimated Primary Completion Date: | No date given |